Neuroleptic Malignant Syndrome: A Primary Care Perspective

Overview

Journal Prim Care Companion J Clin Psychiatry

Specialty Psychiatry

Date 2004 Oct 30

PMID 15514687

Citations 3

Authors

Sanjay Gupta

Nikhil D Nihalani

Affiliations

Soon will be listed here.

Abstract

In recent years, there has been an increased use of neuroleptic agents in the primary care setting. Neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapy that can be missed if not suspected. This manuscript reviews the diagnosis and management of NMS in the primary care setting. There is a lack of prospective data, and most of the information is obtained from case series. Physicians need to have a high index of suspicion with regard to excluding NMS in patients taking neuroleptics and presenting with hyperthermia.

Citing Articles

Effect of post-pyloric Dobhoff tube retention during gastrojejunostomy for reduction of fluoroscopic time and radiation dose.

Thompson T, Small C, Davis H, Lazarowicz M, Vogel J, Heithaus R Diagn Interv Radiol. 2023; 29(5):710-712.

PMID: 36994972 PMC: 10679547. DOI: 10.4274/dir.2022.221473.

Neuroleptic malignant syndrome.

Rajamani B, Kumar Y, Rahman S J Family Med Prim Care. 2016; 5(1):178-80.

PMID: 27453870 PMC: 4943133. DOI: 10.4103/2249-4863.184660.

Serotonin syndrome with paroxetine overdose: a case report.

Canan F, Korkmaz U, Kocer E, Onder E, Yildirim S, Ataoglu A Prim Care Companion J Clin Psychiatry. 2008; 10(2):165-7.

PMID: 18458731 PMC: 2292445. DOI: 10.4088/pcc.v10n0213g.

References

Shalev A, Hermesh H, Munitz H . Mortality from neuroleptic malignant syndrome. J Clin Psychiatry. 1989; 50(1):18-25. View

Raitasuo V, Vataja R, Elomaa E . Risperidone-induced neuroleptic malignant syndrome in young patient. Lancet. 1994; 344(8938):1705. DOI: 10.1016/s0140-6736(94)90489-8. View

Pope Jr H, Cole J, Choras P, Fulwiler C . Apparent neuroleptic malignant syndrome with clozapine and lithium. J Nerv Ment Dis. 1986; 174(8):493-5. DOI: 10.1097/00005053-198608000-00010. View

Davis J, Janicak P, Sakkas P, Gilmore C, Wang Z . Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome. Convuls Ther. 1991; 7(2):111-120. View

Friedman J, Feinberg S, Feldman R . A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal. JAMA. 1985; 254(19):2792-5. View

Tarsy D . Risperidone and neuroleptic malignant syndrome. JAMA. 1996; 275(6):446. View

Webster P, Wijeratne C . Risperidone-induced neuroleptic malignant syndrome. Lancet. 1994; 344(8931):1228-9. DOI: 10.1016/s0140-6736(94)90542-8. View

Rosebush P, Stewart T . A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry. 1989; 146(6):717-25. DOI: 10.1176/ajp.146.6.717. View

Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T . Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004; 65(4):464-70. DOI: 10.4088/jcp.v65n0403. View

10.

Rosebush P, Stewart T, Gelenberg A . Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry. 1989; 50(8):295-8. View

11.

Addonizio G, Susman V, Roth S . Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry. 1987; 22(8):1004-20. DOI: 10.1016/0006-3223(87)90010-2. View

12.

Blair D, Dauner A . Neuroleptic malignant syndrome: liability in nursing practice. J Psychosoc Nurs Ment Health Serv. 1993; 31(2):5-12. DOI: 10.3928/0279-3695-19930201-06. View

13.

Pope Jr H, Aizley H, Keck Jr P, McElroy S . Neuroleptic malignant syndrome: long-term follow-up of 20 cases. J Clin Psychiatry. 1991; 52(5):208-12. View

14.

Velamoor V . Neuroleptic malignant syndrome. Recognition, prevention and management. Drug Saf. 1998; 19(1):73-82. DOI: 10.2165/00002018-199819010-00006. View

15.

Gelenberg A, Bellinghausen B, Wojcik J, Falk W, Sachs G . A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. Am J Psychiatry. 1988; 145(4):517-8. DOI: 10.1176/ajp.145.4.517. View

16.

Castillo E, Rubin R, Holsboer-Trachsler E . Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry. 1989; 146(3):324-8. DOI: 10.1176/ajp.146.3.324. View

17.

Muller T, Becker T, Fritze J . Neuroleptic malignant syndrome after clozapine plus carbamazepine. Lancet. 1988; 2(8626-8627):1500. DOI: 10.1016/s0140-6736(88)90986-5. View

18.

Dave M . Two cases of risperidone-induced neuroleptic malignant syndrome. Am J Psychiatry. 1995; 152(8):1233-4. DOI: 10.1176/ajp.152.8.1233b. View

19.

DeLay J, Pichot P, Lemperiere T, ELISSALDE B, Peigne F . [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses]. Ann Med Psychol (Paris). 1960; 118(1):145-52. View

20.

Scheftner W, Shulman R . Treatment Choice in Neuroleptic Malignant Syndrome. Convuls Ther. 1992; 8(4):267-279. View